The FDA approved phentolamine ophthalmic solution 0.75% (Ryzumvi; Viatris) for the treatment of presbyopia in adults, giving ...

Limited access to care means safety-net ICUs see advanced disease and poorer outcomes, while bias and social media add new ...

Pulmonologists play a key role in comprehensive biomarker testing, helping more patients with lung cancer access precise ...

OneOncology's Larry Bilbrey explains how to guide practices on AI without endorsing products and why technology gaps outweigh ...

FDA granted accelerated approval to dostarlimab-gxly for dMMR or MSI-H locally advanced rectal cancer based on interim phase ...

Intensive blood pressure (BP) lowering reduced the risk of major cardiovascular events by 15% for every 10-mm Hg reduction in ...

Nearly 3 in 4 adults undergoing metabolic bariatric surgery (MBS) at 4 international centers met criteria for clinical ...

The AAO 2026 annual meeting, held in New Orleans, Louisiana, from October 10 to October 12, 2026, was a weekend that provided ...

Older patients with obstructive sleep apnea (OSA) carried a markedly higher burden of cardiometabolic disease and reported ...

For years, pulmonologists treating bronchiectasis had little formal guidance and only off-label tools. That has changed in ...

On the opening day of CHEST 2026 in Phoenix, Arizona, the organization's flagship journal highlights a trio of key papers ...

The FDA approved satralizumab-mwge (Enspryng; Genentech) on October 15, 2026, for adults with thyroid eye disease (TED) ...